Erratum: Long-term outcomes of early enzyme replacement therapy for mucopolysaccharidosis IV: Clinical case studies of two siblings (Diagnostics (2020) 10 (108) DOI: 10.3390/diagnostics10020108)

Sharon Barak, Yair Anikster, Ifat Sarouk, Eve Stern, Etzyona Eisenstein, Tamar Yissar, Nir Sherr-Lurie, Annick Raas-Rothschild, Dafna Guttman

Research output: Contribution to journalComment/debate

Abstract

The authors wish to make the following correction to this paper [1]: In the first paragraph of the Results section: “P1 and P2 started ERT with elosulfase alfa (VIMIZIM® by BioMarin

Original languageEnglish
Article number480
JournalDiagnostics
Volume10
Issue number7
DOIs
StatePublished - Jul 2020

Fingerprint

Dive into the research topics of 'Erratum: Long-term outcomes of early enzyme replacement therapy for mucopolysaccharidosis IV: Clinical case studies of two siblings (Diagnostics (2020) 10 (108) DOI: 10.3390/diagnostics10020108)'. Together they form a unique fingerprint.

Cite this